Cutaneous T-cell Lymphoma Market Landscape Report 2024: Comprehensive Insights About 25+ Companies and 30+ Pipeline Drugs
November 21, 2024 04:12 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Cutaneous T-cell lymphoma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides...
T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - Regulatory Support Drives Fast-Track Development of Novel T Cell Lymphoma Drugs from Eisai, Takeda, and Rhizen Pharmaceuticals
November 06, 2024 04:59 ET
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "T-Cell Lymphoma Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.T-Cell lymphoma is a type of...
T cell Lymphoma Therapeutics Research 2024: Comprehensive Insights about 90+ Companies and 90+ Pipeline Drugs
July 23, 2024 09:57 ET
|
Research and Markets
Dublin, July 23, 2024 (GLOBE NEWSWIRE) -- The "T cell Lymphoma - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...